Company intelligence / Profile preview

Araya

Latham, New York, United Statesaraya-usa.com ↗

Ownership: Private
Development stage: Other

Overview

Araya is an independent, transparent pharmacy benefit manager with over 20 years of experience. It acts as a third-party administrator for prescription drug claims and does not own pharmacies or generate revenue from the products dispensed. Instead, it aligns incentives with clients to ensure cost-effective and clinically appropriate medication access. In 2024, Araya expanded its provider network through a partnership with Mark Cuban Cost Plus Drug Company to further improve affordability and transparency in medication costs

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Mark Cuban Cost Plus Drug Company

Beyond the preview

Go deeper on Araya.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Araya.

Explore the full profile